StreetInsider.com News Articles

Rapid Micro Biosystems to Participate in Upcoming Investor Conferences

Fri, 04 Sep 2026 16:05:00 -0400

LEXINGTON, Mass., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced plans to participate in the following upcoming investor conferences:

Thursday, September 10, 2026 - Lake Street’s 10^th Annual Best Ideas Growth (BIG) Conference in New York, NY. The Company will participate in one-on-one investor meetings.
Thursday, September 24, 2026 - Sidoti Small-Cap Virtual Conference - The Company will present

Rapid Micro Biosystems to Participate in Upcoming Investor Conferences

Fri, 04 Sep 2026 16:05:00 -0400

Thursday, September 10, 2026 - Lake Street’s 10^th Annual Best Ideas Growth (BIG) Conference in New York, NY. The Company will participate in one-on-one investor meetings.
Thursday, September 24, 2026 - Sidoti Small-Cap Virtual Conference - The Company will present

Form SCHEDULE 13G RAPID MICRO BIOSYSTEMS, Filed by: ARMISTICE CAPITAL, LLC

Fri, 14 Aug 2026 10:26:00 -0400

si-local-file:///var/storage/secattach/20260814/26926395.html

Form SCHEDULE 13G RAPID MICRO BIOSYSTEMS, Filed by: ARMISTICE CAPITAL, LLC

Fri, 14 Aug 2026 10:26:00 -0400

si-local-file:///var/storage/secattach/20260814/26926395.html

Form SCHEDULE 13G/A RAPID MICRO BIOSYSTEMS, Filed by: Bain Capital Life Sciences Fund, L.P.

Fri, 14 Aug 2026 07:00:00 -0400

si-local-file:///var/storage/secattach/20260814/26924415.html

Form SCHEDULE 13G/A RAPID MICRO BIOSYSTEMS, Filed by: Bain Capital Life Sciences Fund, L.P.

Fri, 14 Aug 2026 07:00:00 -0400

si-local-file:///var/storage/secattach/20260814/26924415.html

Rapid Micro Biosystems (RPID) Reiterated at Buy by Stifel: Top-Line Results as Expected

Mon, 10 Aug 2026 07:55:28 -0400

Stifel analyst Daniel Arias reiterated a Buy rating and $8.00 price target on Rapid Micro Biosystems Inc (NASDAQ: RPID).

The analyst commented, "RPID 2Q results met expectations on the top-line and saw mixed trends in other parts of the model, though none were tragic, which makes last Friday's stock move look pretty overdone - particularly given the meaningfully better 2H (system placements, EBITDA margins) that should be on the way. Mgmt's tone on customer appetite for box purchased and utilization sounds good, so momentum into 2027 should be good as well. RPID remains a small cap stock fighting for airtime, but

Form 10-Q RAPID MICRO BIOSYSTEMS, For: Jun 30

Fri, 07 Aug 2026 07:33:00 -0400

si-local-file:///var/storage/secattach/20260807/26887559.html

Form 10-Q RAPID MICRO BIOSYSTEMS, For: Jun 30

Fri, 07 Aug 2026 07:33:00 -0400

si-local-file:///var/storage/secattach/20260807/26887559.html

Form 8-K RAPID MICRO BIOSYSTEMS, For: Aug 07

Fri, 07 Aug 2026 07:02:00 -0400

si-local-file:///var/storage/secattach/20260807/26887360.html

Form 8-K RAPID MICRO BIOSYSTEMS, For: Aug 07

Fri, 07 Aug 2026 07:02:00 -0400

si-local-file:///var/storage/secattach/20260807/26887360.html

Rapid Micro Biosystems Reports Second Quarter 2026 Financial Results

Fri, 07 Aug 2026 07:00:00 -0400

Reports second quarter 2026 total revenue of $8.1 million, representing 11% growth compared to the second quarter of 2025
- Achieved a significant milestone with the 200th Growth Direct system placed globally; placed four Growth Direct systems and completed nine validations in the second quarter 2026
- Second quarter consumable revenue increased more than 20% year-over-year
- Second quarter recurring revenue increased 14% year-over-year; comprised 63% of total revenue
Reports record second quarter total gross margin of 15%, an increase of 11 percentage points compared to the second quarter of 2025
Merck

Rapid Micro Biosystems Reports Second Quarter 2026 Financial Results

Fri, 07 Aug 2026 07:00:00 -0400

Reports second quarter 2026 total revenue of $8.1 million, representing 11% growth compared to the second quarter of 2025
Achieved a significant milestone with the 200th Growth Direct system placed globally; placed four Growth Direct systems and completed nine validations in the second quarter 2026
Second quarter consumable revenue increased more than 20% year-over-year
Second quarter recurring revenue increased 14% year-over-year; comprised 63% of total revenue

Reports record second quarter total gross margin of 15%, an increase of 11 percentage points compared to the second quarter of 2025
Merck

Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Tue, 04 Aug 2026 16:30:00 -0400

LEXINGTON, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced the grants on August 3, 2026, of 90,000 restricted stock units (“RSUs”) of the Company’s Class A common stock (“Common Stock”) and a non-qualified stock option to purchase 170,000 shares of Common Stock (the “Option”), all as a material inducement to employment for a new employee. All such equity awards were made under the Company’s Inducement

Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Tue, 04 Aug 2026 16:30:00 -0400

LEXINGTON, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced the grants on August 3, 2026, of 90,000 restricted stock units (“RSUs”) of the Company’s Class A common stock (“Common Stock”) and a non-qualified stock option to purchase 170,000 shares of Common Stock (the “Option”), all as a material inducement to employment for a new employee. All such equity awards were made under the Company’s Inducement

Form 4 RAPID MICRO BIOSYSTEMS, For: Jul 24 Filed by: Kollender Richard S

Fri, 24 Jul 2026 18:31:00 -0400
si-local-file:///var/storage/secattach/20260724/26814508.html

Form 4 RAPID MICRO BIOSYSTEMS, For: Jul 24 Filed by: Kollender Richard S

Fri, 24 Jul 2026 18:31:00 -0400
si-local-file:///var/storage/secattach/20260724/26814508.html

Form 4 RAPID MICRO BIOSYSTEMS, For: Jul 22 Filed by: Spignesi Robert G. Jr.

Fri, 24 Jul 2026 18:30:00 -0400
si-local-file:///var/storage/secattach/20260724/26814502.html

Form 4 RAPID MICRO BIOSYSTEMS, For: Jul 22 Filed by: Spignesi Robert G. Jr.

Fri, 24 Jul 2026 18:30:00 -0400
si-local-file:///var/storage/secattach/20260724/26814502.html

Rapid Micro Biosystems to Announce Second Quarter 2026 Financial Results on August 7, 2026

Thu, 23 Jul 2026 17:15:00 -0400

LEXINGTON, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release second quarter 2026 financial results prior to the market open on Friday, August 7, 2026.

In conjunction with the release, the Company’s management team will host a webcast conference call at 8:30 a.m. ET on Friday, August 7, 2026. The live audio webcast will be accessible on the Company’s website and can be accessed with

Rapid Micro Biosystems to Announce Second Quarter 2026 Financial Results on August 7, 2026

Thu, 23 Jul 2026 17:15:00 -0400

LEXINGTON, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release second quarter 2026 financial results prior to the market open on Friday, August 7, 2026.

In conjunction with the release, the Company’s management team will host a webcast conference call at 8:30 a.m. ET on Friday, August 7, 2026. The live audio webcast will be accessible on the Company’s website and can be accessed with

Rapid Micro Biosystems to Announce Second Quarter 2026 Financial Results on August 7, 2026

Thu, 23 Jul 2026 17:15:00 -0400

LEXINGTON, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release second quarter 2026 financial results prior to the market open on Friday, August 7, 2026.

In conjunction with the release, the Company’s management team will host a webcast conference call at 8:30 a.m. ET on Friday, August 7, 2026. The live audio webcast will be accessible on the Company’s website and can be accessed with

Rapid Micro Biosystems to Announce Second Quarter 2026 Financial Results on August 7, 2026

Thu, 23 Jul 2026 17:15:00 -0400

LEXINGTON, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release second quarter 2026 financial results prior to the market open on Friday, August 7, 2026.

In conjunction with the release, the Company’s management team will host a webcast conference call at 8:30 a.m. ET on Friday, August 7, 2026. The live audio webcast will be accessible on the Company’s website and can be accessed with

Form 144 RAPID MICRO BIOSYSTEMS, Filed by: Wilson John J. Addington

Wed, 08 Jul 2026 16:10:00 -0400
si-local-file:///var/storage/secattach/20260708/26747649.html

Form 144 RAPID MICRO BIOSYSTEMS, Filed by: Wilson John J. Addington

Wed, 08 Jul 2026 16:10:00 -0400
si-local-file:///var/storage/secattach/20260708/26747649.html